Skip to main navigation
Skip to search
Skip to main content
Taipei Medical University Home
Help & FAQ,
English
中文
Home
Profiles
Research units
Projects
Research output
Datasets
Activities
Search by expertise, name or affiliation
Development of small molecule inhibitors targeting PBX1 transcription signaling as a novel cancer therapeutic strategy
Yao An Shen
, Jin Jung
, Geoffrey D. Shimberg
, Fang Chi Hsu
, Yohan Suryo Rahmanto
, Stephanie L. Gaillard
, Jiaxin Hong
, Jürgen Bosch
, Ie Ming Shih
, Chi Mu Chuang
, Tian Li Wang
Graduate Institute of Clinical Medicine
Department of Pathology
TMU Research Center of Cancer Translational Medicine
Research output
:
Contribution to journal
›
Article
›
peer-review
22
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Development of small molecule inhibitors targeting PBX1 transcription signaling as a novel cancer therapeutic strategy'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine and Dentistry
Malignant Neoplasm
100%
Cancer Cell
100%
Carcinogenesis
50%
Neoplasm
50%
Cancer
50%
Stem Cell
50%
Cell Function
50%
Ovarian Tumor
50%
Carboplatin
50%
Organogenesis
50%
Cell Renewal
50%
Transcription Factors
50%
Biochemistry, Genetics and Molecular Biology
Small Molecule
100%
Transcription
100%
PBX1
100%
Cancer Cell
22%
Cell Function
11%
Stem Cell
11%
Organogenesis
11%
Cell Renewal
11%
Carcinogenesis
11%
Transcription Factors
11%
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
100%
Lead Compound
33%
Ovary Tumor
33%
Neoplasm
33%
Carcinogenesis
33%
Transcription Factors
33%
Carboplatin
33%